ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.

Published in: PLoS medicine (2021)

Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.

Keyphrases